EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Proteostasis disruption under hypoxia: therapeutic targets in cancer and neurodegenerative diseases

Susi Rahmiyati, Ani Retno Prijanti, Sri Widia A Jusman, Syarifah Dewi

Acta Biochimica Indonesiana · 2025

DOI: 10.32889/actabioina.142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biochimica Indonesiana, 2025. Verfasst von Susi Rahmiyati und 3 weiteren Autor:innen. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteostasis, the integrated network regulating protein synthesis, folding, trafficking, and degradation, is essential for cellular function and organismal health. Reduced oxygen availability disrupts proteostasis through increased reactive oxygen species (ROS) production, endoplasmic reticulum (ER) stress, impaired ATP-dependent protein folding, and altered chaperone expression. In cancer, tumor cells exploit chronic unfolded protein response (UPR) signaling to enhance survival, angiogenesis, and therapeutic resistance. Inhibition of IRE1α and PERK pathways has shown efficacy in preclinical models, though clinical translation faces challenges including off-target toxicity. In neurodegenerative diseases—Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis—chronic hypoxia accelerates protein aggregate accumulation through oxidative modifications and impaired autophagy-lysosome function. Therapeutic strategies targeting γ-secretase, BACE1, and protein clearance pathways have demonstrated limited clinical success despite mechanistic rationale. Understanding hypoxia-induced proteostasis failure may inform therapeutic development, though significant obstacles remain in translating preclinical findings to effective treatments for cancer and neurodegenerative diseases.

Zitieren

APA

Rahmiyati, S., Prijanti, A. R., Jusman, S. W. A., & Dewi, S. (2025). Proteostasis disruption under hypoxia: therapeutic targets in cancer and neurodegenerative diseases. Acta Biochimica Indonesiana. https://doi.org/10.32889/actabioina.142

Vancouver

Rahmiyati S, Prijanti AR, Jusman SWA, Dewi S. Proteostasis disruption under hypoxia: therapeutic targets in cancer and neurodegenerative diseases. Acta Biochimica Indonesiana. 2025. doi:10.32889/actabioina.142

BibTeX
@article{Rahmiyati2025,
  author = {Rahmiyati, Susi and Prijanti, Ani Retno and Jusman, Sri Widia A and Dewi, Syarifah},
  title = {Proteostasis disruption under hypoxia: therapeutic targets in cancer and neurodegenerative diseases},
  journal = {Acta Biochimica Indonesiana},
  year = {2025},
  doi = {10.32889/actabioina.142}
}
Kostenlos starten →